---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029227"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:55:57.438273+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharma rebrands to TNF Pharmaceuticals; ticker changes to TNFA on Nasdaq

## Summary
- Name changed from MyMD Pharmaceuticals to TNF Pharmaceuticals effective July 22, 2024.
- Common stock began trading under new ticker 'TNFA' on Nasdaq effective July 24, 2024, replacing 'MYMD'.
- Rebranding aligns with therapeutic focus on TNF-alpha inhibition; lead candidate MYMD-1 unchanged.
- No change to CUSIP or shareholder action required; stockholder approval was not needed.
- Company plans mid-stage clinical trials of MYMD-1 for sarcopenia following positive Phase 2 results.

## SEC filing metadata
- accession: 0001493152-24-029227
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224029227/0001493152-24-029227-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224029227/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029227
- JSON: https://secwatch.observer/filing/0001493152-24-029227.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029227.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.